ResultsIQ › Latest results › EP Biocomposites Ltd
EP Biocomposites Ltd (EPBIO) quarterly results
NSE: EPBIO · BSE: 543595
AI summary: Results press release, Q4 FY26
Results press release of 29 May 2026, summarised by AI from the filing.
Net worth crossed ₹12 cr as on March 31, 2026, with partial debt repayment and improved liquidity.
Key takeaways
- Balance sheet Net worth crossed ₹12 cr as on March 31, 2026, with partial debt repayment and improved liquidity.
- Returns ROI 14% and ROCE 16% during FY26.
- IPO proceeds Utilized towards capacity expansion, working capital, and business growth initiatives.
EP Biocomposites Ltd earnings call, investor presentation and press release summaries
- Q4 FY26: Results press release (29 May 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.